Mounjaro side effects are usually linked to how tirzepatide changes appetite, digestion and blood sugar. Many side effects are digestive and typically mild, especially when starting treatment or after a dose increase. However, the side effects of Mounjaro still matter because severe or persistent symptoms can affect daily life.
This guide explains possible side effects, how Mounjaro works in the body, management steps, and when to review your weight loss treatment plan with a doctor.
Why can Mounjaro cause side effects?
Mounjaro is a prescription medicine containing tirzepatide. It is used for type 2 diabetes and, in eligible adults, for weight management and weight loss alongside diet and physical activity. [1, 2] In the UK, the National Institute for Health and Care Excellence has recommended tirzepatide for managing overweight and obesity in selected adults. [3]
Mounjaro affects GIP and GLP-1 pathways, which regulate appetite, blood sugar and digestion. This is how Mounjaro can support weight loss and weight loss goals, but also why side effects such as nausea, diarrhoea, constipation, stomach pain, vomiting, fatigue and reduced appetite can happen. [1]
The medicine slows gastric emptying, so food may stay in the stomach longer, appetite can fall, and the body adjusts over time. That adjustment is why symptoms are often most noticeable early on or after the dose changes.
What side effects can Mounjaro cause?
The side effects of Mounjaro vary. Some people have few side effects, while others notice digestive symptoms or tiredness. The patient information leaflet lists possible side effects and says when to contact a doctor. [1]
Overview of the most common side effects of Mounjaro
The most common side effects include nausea, diarrhoea, vomiting, constipation, stomach pain and reduced appetite. [1, 4] In clinical trials, digestive side effects were generally mild or moderate and were more common while the dose was being raised. [2]
The side effects of Mounjaro may depend on dose, food choices, hydration, diabetes medicines and other factors. If side effects persist, worsen, or stop you eating and drinking normally, speak with a healthcare professional.
Digestive side effects
Digestive side effects are the main reason people feel unwell when taking Mounjaro. Nausea, diarrhoea, constipation, indigestion, bloating, reflux, abdominal pain and vomiting can occur because the tirzepatide slows stomach emptying and affects how the digestive system functions. [1, 2]
These side effects are often manageable, but dehydration can become a problem if vomiting or diarrhoea continues. Fluids, small bland meals and avoiding high-fat foods may reduce discomfort. If you cannot keep fluids down, contact a doctor immediately.
Other common side effects including injection site reactions
Other common effects include tiredness, dizziness, burping, reflux, reduced appetite and injection site reactions. [1, 2] An injection site reaction may involve redness, itching, tenderness or mild swelling around the injection site.
Rotate the injection site each week and follow the instructions for the Mounjaro pen. Mounjaro injections are supplied in a pre-filled pen. If an injection site reaction spreads, becomes very painful, or looks infected, seek advice from a healthcare professional.
Mounjaro side effects timeline
Side effects can start at different points in a weight loss journey. Some notice symptoms quickly; while others do not develop side effects until the dose is increased.
Side effects in the first week
They can start in the first few days after the first injection, especially nausea, reduced appetite, stomach pain, constipation or diarrhoea. These effects usually reflect how the body adjusts to slower digestion and appetite changes.
For many people, early side effects are typically mild. Smaller portions, lighter meals, fluids and fresh air during nausea may help.
Side effects after each dose increase
Side effects are often more noticeable after each dose increase. [2] This means that, as Mounjaro affects the body, time to adjust is required.
If symptoms after a new strength feel stronger than expected, do not change the next dose yourself. Ask the prescriber whether to stay at the current dose, delay escalation, or review the treatment. Patients taking Mounjaro with insulin or sulfonylureas may also need advice about low blood sugar. [1]
Mounjaro long-term side effects: what is known
Long-term effects are still being monitored because newer weight loss medications continue to be followed after approval. Known serious side effects include pancreatitis, gallbladder problems, kidney issues related to dehydration, severe allergic reactions and eye-monitoring concerns in some people with diabetes. [1, 2]
Longer-term weight loss itself can also change the body. Faster weight change may contribute to hair loss, gallstones, skin changes and altered energy levels.
How long do Mounjaro side effects last?

People often ask “how long will Mounjaro side effects last” because they want to know if discomfort is temporary. Mild digestive symptoms usually last a few days to a few weeks, and they often ease as the body adjusts. [1, 2]
Serious side effects may last longer and need treatment. If symptoms are severe, keep returning, or interfere with daily activities, do not simply wait for them to pass. Speak to a healthcare professional, especially if you have persistent vomiting, signs of dehydration, hypoglycaemia, stomach pain, or allergic reactions.
Serious and rare side effects of Mounjaro
Most side effects of Mounjaro are digestive, but rare cases can be serious side effects involving the pancreas, gallbladder, kidneys, eyes, or immune system.
Pancreatitis
Acute pancreatitis has been reported in people treated with tirzepatide. [2] Symptoms can include persistent severe stomach pain, severe pain spreading to the back, vomiting or feeling very unwell.
Do not ignore severe stomach pain while taking Mounjaro. The SmPC advises immediate medical attention if acute pancreatitis symptoms occur; if suspected, tirzepatide should be stopped while it is assessed. [2]
Gallbladder problems
Mounjaro may cause gallbladder problems and an increased risk of gallstones, including cholecystitis. [2] In weight management clinical trials, reported gallbladder events were linked with weight reduction. [2]
Symptoms can include severe abdominal pain, upper-right stomach pain, pain after fatty meals, fever, yellowing skin or eyes, or nausea that does not settle. Weight loss can also increase gallstone risk, so gallbladder symptoms should be reviewed.
Kidney problems
Kidney problems can occur if nausea, vomiting or diarrhoea lead to dehydration. The Mounjaro SmPC warns that digestive side effects may lead to fluid loss and worsening kidney function, including acute renal failure in rare cases. [2]
This is more concerning with kidney disease or if you cannot keep fluids down. Seek help if you pass very little urine, feel faint or keep vomiting.
Thyroid cancer risk
The topic of thyroid cancer Mounjaro warnings needs careful wording. In animal studies, tirzepatide caused thyroid C-cell tumours in rats, but the human relevance is unknown. [2] This does not mean Mounjaro has been proven to cause thyroid cancer in humans.
Any concerns should be discussed before starting treatment, especially if you or a close family member has had medullary thryroid carcinome or if you have multiple endocrine neoplasia syndrom type 2 (MEN2). Contact a doctor if you notice a neck lump, hoarseness, trouble swallowing or unexplained breathing changes. Searches such as “Mounjaro side effects cancer” or “thyroid cancer Mounjaro” should lead to medical advice, not panic.
Diabetic retinopathy
Diabetic retinopathy is an eye condition linked with diabetes. Tirzepatide has not been studied in some people with more severe disease, and caution with monitoring is advised. [2]
People with diabetes should keep eye screening appointments and report vision changes. Blurred vision, sudden visual changes or eye symptoms should be discussed with a doctor, particularly when glucose control is improving quickly.
Severe allergic reactions
Allergic reactions can happen with medicines, including Mounjaro. Product information lists hypersensitivity reactions, and post-marketing reports include anaphylactic reaction and angioedema. [2]
A serious allergic reaction is a medical emergency. Seek urgent help if allergic reactions include swelling of the face, lips, tongue or throat, difficulty breathing, problems breathing, severe rash, fainting or collapse. Mild allergic reactions should still be reported to a healthcare professional, especially if they recur after injections.
Mounjaro side effects from rapid weight loss
Some side effects during a weight loss journey may be caused by losing weight quickly rather than by the medicine alone. Reduced appetite can make it harder to eat enough protein, fibre, vitamins and fluids, especially early in treatment.
Low blood pressure, low blood sugar and energy levels
Quick weight change, reduced food intake, dehydration and changes in diabetes medicines can affect energy. Dizziness may be linked to dehydration, low blood pressure or glucose changes, depending on the person and medicines used.
Low blood sugar is more likely when Mounjaro is used with insulin or sulfonylureas. [1, 2] Symptoms can include sweating, hunger, confusion, fast heartbeat, weakness and dizziness. Your doctor should explain what to do if this applies to you.
Skin changes from rapid weight loss
Hair loss has been reported in weight management studies with tirzepatide and was generally mild, with most people recovering while continuing treatment. [2] It can also be linked to quick weight change, low protein intake, stress or nutritional gaps.
Skin changes may also become more visible as body weight falls. A balanced diet, adequate protein, hydration and supervised losing of weight gradually support health during weight loss treatment.
Mounjaro and mental health

Mental health can change during weight management for many reasons, including appetite change, physical side effects, body image, glucose changes and stress. Current MHRA conclusions for GLP-1 receptor agonists did not support a causal link with suicidal thoughts or self-harm, but mood symptoms should still be taken seriously. [6]
Contact your healthcare team if your mental health changes after treatment begins. This is especially important if low mood, anxiety, disordered eating thoughts or self-harm thoughts appear or worsen.
Who should not take Mounjaro?
Mounjaro is not suitable for everyone. A prescriber should review your medical history, medical conditions, current medicines, pregnancy plans and breastfeeding status before prescribing Mounjaro. They should prescribe Mounjaro only when the expected benefit justifies the risks.
People should not use it if they are allergic to tirzepatide or any ingredient in the medicine. [2] It should not be used during pregnancy. People searching for pregnant breastfeeding advice, planning pregnancy or using oral contraceptives should ask for specific guidance before treatment. [1, 2]
People using oral contraceptives should switch to a non-oral contraceptive method or add a barrier method for 4 weeks after starting Mounjaro and for 4 weeks after each dose increase. This applies whether Mounjaro is being used for type 2 diabetes or weight management. [2]
Before taking Mounjaro, tell your clinician about pancreatitis, severe digestive disease, kidney disease, gallbladder disease, diabetic eye disease, insulin or sulfonylurea use, and any personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 (MEN2).
When taking Mounjaro, before surgery or procedures involving general anaesthesia or deep sedation, tell the healthcare team that you are taking Mounjaro because delayed gastric emptying may increase aspiration risk. [5] A regulated provider should prescribe Mounjaro only after checking that these risks have been considered.
How to manage Mounjaro side effects
Many Mounjaro side effects can be managed with small changes, but do not push through severe symptoms. For nausea, try smaller, bland meals, eat slowly, avoid high-fat foods, and stop when full. For diarrhoea or vomiting, hydration is important because fluid loss can worsen dizziness and kidney problems.
For constipation, increase fluids gradually, move regularly if you can, and eat fruits, vegetables and fibre if tolerated. A pharmacist can advise on suitable over-the-counter remedies for constipation, diarrhoea or indigestion, but check first if you have other medical conditions.
For local reactions, rotate where you inject, avoid sore or bruised skin, and follow the device instructions. If you miss a dose, follow the patient information leaflet for a missed dose and do not double up near the next dose without advice. If possible side effects are disrupting daily life, ask your prescriber whether the schedule or weight loss treatment needs review.
Mounjaro vs Wegovy: which has fewer side effects?
Wegovy and Mounjaro are both weight loss medications given by injection, but they contain different active ingredients. Mounjaro contains tirzepatide, while Wegovy contains semaglutide.
Both can cause digestive side effects such as nausea, diarrhoea, vomiting, constipation and stomach pain. [2, 7] It is not useful to ask which has fewer side effects overall, because tolerability varies between people. One person may feel better on Wegovy, while another may do better on Mounjaro. A clinician should consider your health, previous adverse effects, goals and current medicines before recommending weight loss injections.
When to contact a doctor
Contact a doctor if side effects are severe, persistent, worsening, or stop you from eating and drinking. Seek urgent medical attention for persistent vomiting, signs of dehydration, symptoms of pancreatitis, gallbladder symptoms, allergic reactions, difficulty breathing, fainting, or severe stomach pain.
You should also contact a doctor immediately if you develop neck swelling, swallowing difficulty, hoarseness, severe abdominal pain, yellowing of the skin or eyes, or sudden vision changes. If you want to buy Mounjaro, use a regulated provider that checks suitability rather than relying on unverified weight loss medicine sources.
Frequently asked questions about Mounjaro side effects
These answers cover common practical questions, including what the side effects of Mounjaro are that need urgent help.
What are the side effects of Mounjaro you can expect?
The side effects of Mounjaro commonly include nausea, diarrhoea, vomiting, constipation, tummy pain, indigestion, reduced appetite, tiredness, dizziness and local reactions. [1, 2] Serious side effects are less common but can include pancreatitis, gallbladder problems, kidney injury from dehydration, severe allergic reactions and eye issues in some people with diabetes.
The worst side effects of Mounjaro are those that may signal pancreatitis, gallbladder disease, severe dehydration, acute kidney injury, severe allergic reactions or serious hypoglycaemia.
How long do Mounjaro side effects last?
People often ask “how long do Mounjaro side effects last” because early nausea or diarrhoea can be worrying. Mild side effects usually settle within days or weeks as the body adjusts. [1]
If side effects do not improve, become severe, or return after each escalation, speak with a healthcare professional. Serious side effects may require longer treatment and should not be self-managed.
When do Mounjaro side effects start?
They may start within the first few days of starting treatment, and they can also appear after the dose changes.
Digestive side effects are most common during early treatment or escalation. [2] Keeping meals smaller, avoiding rich food and drinking enough fluids may make the early stage easier.
Can Mounjaro cause cancer?
The thyroid cancer Mounjaro issue comes from animal data showing thyroid C-cell tumours in rats; the relevance to humans is unknown. [2] Mounjaro has not been proven to cause thyroid cancer in humans.
However, any concerns should be discussed with a prescriber, especially if there are risk factors or symptoms such as a neck lump, hoarseness or swallowing difficulty. This is the safest way to handle Mounjaro and cancer concerns.
Does Mounjaro cause hair loss?
Hair loss has been reported in weight management clinical trials with tirzepatide. [2] It may also occur during fast weight change because eating less can reduce protein and micronutrient intake.
Hair loss is usually not a medical emergency, but raise it if it is distressing, persistent or linked with tiredness or poor intake. A balanced diet and gradual weight loss under medical supervision can help reduce avoidable triggers.
Can I drink alcohol while taking Mounjaro?
You may be able to drink alcohol, but heavy drinking can worsen nausea, dehydration and glucose swings. If you have diabetes, alcohol can also make hypoglycaemia harder to recognise or manage.
Ask your prescriber what is safe for you. It is especially important to get advice if you take insulin, sulfonylureas or other medicines that affect blood sugar. Some people may also need advice before taking Mounjaro with other treatments.
-
[1] Mounjaro KwikPen 2.5 mg solution for injection in pre-filled pen: patient information leaflet. electronic Medicines Compendium. https://www.medicines.org.uk/emc/product/15481/pil
[2] Mounjaro KwikPen 2.5 mg solution for injection in pre-filled pen: summary of product characteristics. electronic Medicines Compendium. https://www.medicines.org.uk/emc/product/15481/smpc
[3] National Institute for Health and Care Excellence. Tirzepatide for managing overweight and obesity. Technology appraisal guidance TA1026. Published December 23, 2024. Updated September 1, 2025. https://www.nice.org.uk/guidance/ta1026
[4] European Medicines Agency. Mounjaro. European Medicines Agency. https://www.ema.europa.eu/en/medicines/human/EPAR/mounjaro
[5] Medicines and Healthcare products Regulatory Agency. GLP-1 and dual GIP/GLP-1 receptor agonists: potential risk of pulmonary aspiration during general anaesthesia or deep sedation. GOV.UK. Published January 28, 2025. https://www.gov.uk/drug-safety-update/glp-1-and-dual-gip-slash-glp-1-receptor-agonists-potential-risk-of-pulmonary-aspiration-during-general-anaesthesia-or-deep-sedation
[6] Medicines and Healthcare products Regulatory Agency. MHRA finds evidence does not support a link between glucagon-like peptide-1 receptor agonists and suicidal and self-injurious thoughts and actions. GOV.UK. Published September 4, 2024. https://www.gov.uk/government/news/mhra-finds-evidence-does-not-support-a-link-between-glucagon-like-peptide-1-glp-1-receptor-agonists-and-suicidal-and-self-injurious-thoughts-and-act
[7] Wegovy 2.4 mg FlexTouch solution for injection in pre-filled pen: summary of product characteristics. electronic Medicines Compendium.https://www.medicines.org.uk/emc/product/13803/smpc